Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.WT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Reason 27 not to sell out to Big Pharma.

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Dec 19, 2022 9:56pm

269 Views

Post# 35181254

RE:Reason 27 not to sell out to Big Pharma.

Gojotv ...

1. How much time it takes to build a sale task force that will have it entries in oncology's physician and uro loi gists offices?
2. How much does it cost to market your treatment? Include sales rep salaries and travel expenses
3. BioNTech grew much faster when teaming up with Pfizer (high of 67B$, current 37B$).
4. Say bye bye to upfront payments and royalties that could finance your GBM and NSCLC indications

<< Previous

Bullboard Posts

Next >>

Xebra Brands reveals first CBD product purchase order